- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02143453
Comparative Study of High Intensity Interval Training and Endurance Training in Juvenile Obesity
May 20, 2014 updated by: Bruno Gualano, University of Sao Paulo
Exercise is an effective strategy to manage juvenile obesity; however this ideal exercise training mode is still unclear.
In this study, the investigators compared the health-related effects of high intensity interval training versus endurance training in obese children.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
39
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sao Paulo, Brazil
- General Hospital (School of Medicine, University of Sao Paulo)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 12 years (Child)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- age between 8 and 12 years
- Body mass index (BMI) = 95th percentile, according to the First National Health and Nutrition Examination Survey
- no pharmacological treatment
- no evidence of metabolic, hormonal, orthopedic, and cardiovascular disease at the time of the study's commencement
- no participation in any regular exercise training program (except physical education classes, two days a week) at least 6 months before the commencement of the study and throughout the protocol.
Exclusion Criteria:
- non-obese participants
- physically active participants
- participants with cardiovascular diseases or any other condition that could preclude the participation in the the exercise training program
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High intensity interval training
|
3 to 6 sets of 60-second sprints at 100% of the peak velocity interspersed by a 3-min active recovery period.
|
|
Experimental: Endurance training
|
30 to 60-minute continuous exercise at 80% of the peak heart rate
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
body mass index (BMI)
Time Frame: 12 weeks
|
12 weeks
|
|
aerobic conditioning (VO2max)
Time Frame: 12 weeks
|
12 weeks
|
|
insulin sensitivity (HOMA-index)
Time Frame: 12 weeks
|
12 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2010
Primary Completion (Actual)
August 1, 2011
Study Completion (Actual)
August 1, 2011
Study Registration Dates
First Submitted
May 18, 2014
First Submitted That Met QC Criteria
May 20, 2014
First Posted (Estimate)
May 21, 2014
Study Record Updates
Last Update Posted (Estimate)
May 21, 2014
Last Update Submitted That Met QC Criteria
May 20, 2014
Last Verified
May 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HIIT in Juvenile Obesity
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.